1. TSLP Inhibitors for Asthma: Current Status and Future Prospects

   • Maria Gabriella Matera
   • Paola Rogliani
   • Mario Cazzola

   Leading Article 20 February 2020 Pages: 449 - 458

   

2. Mechanisms of Resistance to PD-1 Checkpoint Blockade

   • Justin C. Moser
   • Siwen Hu-Lieskovan

   Leading Article 24 February 2020 Pages: 459 - 465

3. Glucokinase Activators for Type 2 Diabetes: Challenges and Future Developments

   • Konstantinos A. Toulis
   • Krishnarajah Nirantharakumar
   • Abd A. Tahrani

   Leading Article 11 March 2020 Pages: 467 - 475

   

4. Third-Line Antidiabetic Therapy Intensification Patterns and Glycaemic Control in Patients with Type 2 Diabetes in the USA: A Real-World Study

   • Digsu N. Koye
   • Olga Montvida
   • Sanjoy Ketan Paul

   Original Research Article 06 March 2020 Pages: 477 - 487

   

5. Cenegermin: A Review in Neurotrophic Keratitis

   • Emma D. Deeks
   • Yvette N. Lamb

   Adis Drug Evaluation 18 March 2020 Pages: 489 - 494

6. Osilodrostat: First Approval

   • Sean Duggan

   AdisInsight Report 05 March 2020 Pages: 495 - 500

   

7. Trastuzumab Deruxtecan: First Approval

   • Susan J. Keam

   AdisInsight Report 07 March 2020 Pages: 501 - 508

   

8. Teprotumumab: First Approval

   • Anthony Markham

   AdisInsight Report 10 March 2020 Pages: 509 - 512

   

9. Tazemetostat: First Approval

   • Sheridan M. Hoy

   AdisInsight Report 12 March 2020 Pages: 513 - 521

   

10. Correction to: Ubrogepant: First Approval

    • Lesley J. Scott

    Correction Open access 12 March 2020 Pages: 523 - 523